Showing results (161-170 of 468) with videos related to

Sort By:
Pageof 47
Neoplasia (New York, N.Y.)|November 22, 2007
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutineRita Ghosh, Gretchen E Garcia, Katherine Crosby, et al.
Urologic Oncology|February 7, 2012
Prostate cancer risk prediction in a urology clinic in MexicoYuanyuan Liang, Jamie C Messer, Christopher Louden, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
Cancer|January 26, 2005
The association of body mass index and prostate-specific antigen in a population-based studyJacques Baillargeon, Brad H Pollock, Alan R Kristal, et al.
American Journal of Epidemiology|August 10, 2010
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Marian L Neuhouser, et al.
Plos One|October 3, 2012
Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrenceRoble G Bedolla, Jingjing Gong, Thomas J Prihoda, et al.
World Journal of Urology|May 21, 2003
The selenium and vitamin E cancer prevention trialEric A Klein, Scott M Lippman, Ian M Thompson, et al.
Plos One|October 10, 2018
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trialJavier Hernandez, Jonathan Gelfond, Martin Goros, et al.
European Urology|March 31, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons, Jeannette M Schenk, Kathryn B Arnold, et al.
Urologic Oncology|September 24, 2013
Validation of copy number variants associated with prostate cancer risk and prognosisAugust Blackburn, Desiree Wilson, Jonathan Gelfond, et al.
Pageof 47